Login / Signup

Bivalirudin versus heparin for peripheral vascular intervention: You get what you pay for….

Carey D KimmelstielEfthymios N Deliargyris
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
Keyphrases
  • randomized controlled trial
  • venous thromboembolism
  • percutaneous coronary intervention
  • health insurance
  • growth factor
  • chemotherapy induced
  • coronary artery disease